Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000350222 | SCV000341763 | likely benign | not specified | 2016-06-07 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000350222 | SCV000711009 | benign | not specified | 2016-04-08 | criteria provided, single submitter | clinical testing | p.Arg130Arg in exon 03 of COL11A2: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located wi thin the splice consensus sequence, and has been identified in 0.5% (52/10276) o f African chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.bro adinstitute.org; dbSNP rs149638770). |
Gene |
RCV001707615 | SCV000720354 | likely benign | not provided | 2021-04-01 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001707615 | SCV001473005 | benign | not provided | 2020-07-09 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001707615 | SCV002398631 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003957490 | SCV004774187 | likely benign | COL11A2-related condition | 2019-10-31 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |